National Institutes of Health (NIH) researchers have developed a digital replica of crucial eye cells, providing a new tool ...
Good morning, everyone, and thank you for joining us today. Earlier this morning, we issued a press release outlining the positive topline results from our SOL-1 Phase III clinical trial of AXPAXLI, ...
First ever successful demonstration of superiority in an FDA-aligned wet AMD trial comparing a novel investigative agent to an approved anti-VEGF ...
Every school in the Quad-Cities serves students who have special needs, and schools have a few tools to do so, including Individualized Education Programs, or IEPs.